Skip to main content

The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.

Publication ,  Journal Article
Davidson, LJ; Tang, GHL; Ho, EC; Fudim, M; Frisoli, T; Camaj, A; Bowers, MT; Masri, SC; Atluri, P; Chikwe, J; Mason, PJ; Kovacic, JC ...
Published in: Circulation
May 28, 2024

Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their disease course with severe right-sided heart failure, pulmonary hypertension, and life-limiting symptoms that have few durable treatment options. Traditionally, the only treatment for tricuspid valve disease has been medical therapy or surgery; however, there have been increasing interest and success with the use of transcatheter tricuspid valve therapies over the past several years to treat patients with previously limited therapeutic options. The tricuspid valve is complex anatomically, lying adjacent to important anatomic structures such as the right coronary artery and the atrioventricular node, and is the passageway for permanent pacemaker leads into the right ventricle. In addition, the mechanism of tricuspid pathology varies widely between patients, which can be due to primary, secondary, or a combination of causes, meaning that it is not possible for 1 type of device to be suitable for treatment of all cases of tricuspid valve disease. To best visualize the pathology, several modalities of advanced cardiac imaging are often required, including transthoracic echocardiography, transesophageal echocardiography, cardiac computed tomography, and cardiac magnetic resonance imaging, to best visualize the pathology. This detailed imaging provides important information for choosing the ideal transcatheter treatment options for patients with tricuspid valve disease, taking into account the need for the lifetime management of the patient. This review highlights the important background, anatomic considerations, therapeutic options, and future directions with regard to treatment of tricuspid valve disease.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 28, 2024

Volume

149

Issue

22

Start / End Page

e1223 / e1238

Location

United States

Related Subject Headings

  • United States
  • Tricuspid Valve Insufficiency
  • Tricuspid Valve
  • Humans
  • Heart Valve Prosthesis Implantation
  • Heart Valve Diseases
  • Cardiovascular System & Hematology
  • American Heart Association
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davidson, L. J., Tang, G. H. L., Ho, E. C., Fudim, M., Frisoli, T., Camaj, A., … American Heart Association Interventional Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Surgery and Anesthesia; and Council on Cardiovascular and Stroke Nursing. (2024). The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association. Circulation, 149(22), e1223–e1238. https://doi.org/10.1161/CIR.0000000000001232
Davidson, Laura J., Gilbert H. L. Tang, Edwin C. Ho, Marat Fudim, Tiberio Frisoli, Anton Camaj, Margaret T. Bowers, et al. “The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 149, no. 22 (May 28, 2024): e1223–38. https://doi.org/10.1161/CIR.0000000000001232.
Davidson LJ, Tang GHL, Ho EC, Fudim M, Frisoli T, Camaj A, et al. The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association. Circulation. 2024 May 28;149(22):e1223–38.
Davidson, Laura J., et al. “The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation, vol. 149, no. 22, May 2024, pp. e1223–38. Pubmed, doi:10.1161/CIR.0000000000001232.
Davidson LJ, Tang GHL, Ho EC, Fudim M, Frisoli T, Camaj A, Bowers MT, Masri SC, Atluri P, Chikwe J, Mason PJ, Kovacic JC, Dangas GD, American Heart Association Interventional Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Surgery and Anesthesia; and Council on Cardiovascular and Stroke Nursing. The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association. Circulation. 2024 May 28;149(22):e1223–e1238.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

May 28, 2024

Volume

149

Issue

22

Start / End Page

e1223 / e1238

Location

United States

Related Subject Headings

  • United States
  • Tricuspid Valve Insufficiency
  • Tricuspid Valve
  • Humans
  • Heart Valve Prosthesis Implantation
  • Heart Valve Diseases
  • Cardiovascular System & Hematology
  • American Heart Association
  • 4207 Sports science and exercise
  • 3202 Clinical sciences